These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 2037311)
21. Potent adjuvant effect by anti-CD40 in collagen-induced arthritis. Enhanced disease is accompanied by increased production of collagen type-II reactive IgG2a and IFN-gamma. Tellander AC; Michaƫlsson E; Brunmark C; Andersson M J Autoimmun; 2000 Jun; 14(4):295-302. PubMed ID: 10882055 [TBL] [Abstract][Full Text] [Related]
22. Isolation of T cell line capable of protecting mice against collagen-induced arthritis. Kakimoto K; Katsuki M; Hirofuji T; Iwata H; Koga T J Immunol; 1988 Jan; 140(1):78-83. PubMed ID: 2447173 [TBL] [Abstract][Full Text] [Related]
23. [Autoimmunity to collagen, experimental arthritis and rheumatic disease]. Meyer O; Dryll A Ann Biol Clin (Paris); 1986; 44(3):269-74. PubMed ID: 3789478 [TBL] [Abstract][Full Text] [Related]
24. The anti-arthritic and immunosuppressive effects of cyclosporine on arthritis induced in the rat by type II collagen. Henderson B; Staines NA; Burrai I; Cox JH Clin Exp Immunol; 1984 Jul; 57(1):51-6. PubMed ID: 6744674 [TBL] [Abstract][Full Text] [Related]
25. Efficient promotion of collagen antibody induced arthritis (CAIA) using four monoclonal antibodies specific for the major epitopes recognized in both collagen induced arthritis and rheumatoid arthritis. Nandakumar KS; Holmdahl R J Immunol Methods; 2005 Sep; 304(1-2):126-36. PubMed ID: 16125192 [TBL] [Abstract][Full Text] [Related]
26. Induction of effective immunity to Moloney murine sarcoma virus using monoclonal anti-idiotypic antibody as immunogen. Powell TJ; Spann R; Nguyenduc M; Lamon EW J Immunol; 1989 Feb; 142(4):1318-24. PubMed ID: 2536772 [TBL] [Abstract][Full Text] [Related]
27. Induction of Th2 cytokines and control of collagen-induced arthritis by nondepleting anti-CD4 Abs. Chu CQ; Londei M J Immunol; 1996 Sep; 157(6):2685-9. PubMed ID: 8805674 [TBL] [Abstract][Full Text] [Related]
28. Suppression of murine collagen-induced arthritis with monoclonal anti-Ia antibodies and augmentation with IFN-gamma. Cooper SM; Sriram S; Ranges GE J Immunol; 1988 Sep; 141(6):1958-62. PubMed ID: 3139747 [TBL] [Abstract][Full Text] [Related]
29. Type II collagen-induced arthritis in mice. III. Suppression of arthritis by using monoclonal and polyclonal anti-Ia antisera. Wooley PH; Luthra HS; Lafuse WP; Huse A; Stuart JM; David CS J Immunol; 1985 Apr; 134(4):2366-74. PubMed ID: 3855932 [TBL] [Abstract][Full Text] [Related]
30. Epitope specificity of antibody response against human type II collagen in the mouse susceptible to collagen-induced arthritis and patients with rheumatoid arthritis. Iribe H; Kabashima H; Ishii Y; Koga T Clin Exp Immunol; 1988 Sep; 73(3):443-8. PubMed ID: 2463122 [TBL] [Abstract][Full Text] [Related]
31. Treatment with an anti-IL-4 monoclonal antibody blocks suppression of collagen-induced arthritis in mice by oral administration of type II collagen. Yoshino S J Immunol; 1998 Mar; 160(6):3067-71. PubMed ID: 9510213 [TBL] [Abstract][Full Text] [Related]
32. Evolution of collagen arthritis in mice is arrested by treatment with anti-tumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor. Piguet PF; Grau GE; Vesin C; Loetscher H; Gentz R; Lesslauer W Immunology; 1992 Dec; 77(4):510-4. PubMed ID: 1337334 [TBL] [Abstract][Full Text] [Related]
33. Collagen-induced arthritis in rats. Examination of the epitope specificities of circulating and cartilage-bound antibodies produced by outbred and inbred rats using cyanogen bromide-derived peptides purified from heterologous and homologous type II collagens. Cremer MA; Terato K; Watson WC; Griffiths MM; Townes AS; Kang AH J Immunol; 1992 Aug; 149(3):1045-53. PubMed ID: 1634761 [TBL] [Abstract][Full Text] [Related]
34. Native type II collagen-induced arthritis in the rat. II. Relationship between the humoral immune response to native type II collagen and arthritis. Clague RB; Morgan K; Shaw MJ; Holt PJ J Rheumatol; 1980; 7(6):775-82. PubMed ID: 6970813 [TBL] [Abstract][Full Text] [Related]
35. Analysis of the idiotypic network in tumor immunity. Raychaudhuri S; Saeki Y; Chen JJ; Kohler H J Immunol; 1987 Dec; 139(11):3902-10. PubMed ID: 2824616 [TBL] [Abstract][Full Text] [Related]
36. Characterization of monoclonal antibody specific for human type II collagen: possible implication in collagen-induced arthritis. Hirofuji T; Kakimoto K; Hori H; Nagai Y; Saisho K; Sumiyoshi A; Koga T Clin Exp Immunol; 1985 Oct; 62(1):159-66. PubMed ID: 2998657 [TBL] [Abstract][Full Text] [Related]
37. T-cell receptor V beta 8 has no significant suppressive effect on collagen-induced arthritis. Matsuno H; Kadowaki KM; Suzuki H; Ochiai H; Tsuji H Int J Tissue React; 1993; 15(1):1-9. PubMed ID: 8282479 [TBL] [Abstract][Full Text] [Related]
38. Type II collagen-reactive T cell clones from mice with collagen-induced arthritis. Dallman M; Fathman CG J Immunol; 1985 Aug; 135(2):1113-8. PubMed ID: 2409139 [TBL] [Abstract][Full Text] [Related]
39. Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis. Yoshioka T; Nakajima A; Akiba H; Ishiwata T; Asano G; Yoshino S; Yagita H; Okumura K Eur J Immunol; 2000 Oct; 30(10):2815-23. PubMed ID: 11069062 [TBL] [Abstract][Full Text] [Related]